The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Correct me if a wrong put the seller/s have been dumping now for 4 weeks every day and there seems no end to it.
It does seem AM short term fiancé friends are out with there 30% profit nice if you can do it. but it did get the 8*mil we first needed and perhaps there in again with the 13 mil raise by who knows who to double there bubble. Naughty AM.
SWLC You may want to take a good look at the institution investment on Nasdaq they seemed to want there investment in dollars they have just bought over 1mil shares there.
Goldman Sachs new investor .i
We now have 28 iis 300% up over 26weeks and big names to boot investment over 30% up with 20% more new II investors total. 25mil 50%up over 12 weeks word is getting out there .
https://www.nasdaq.com/market-activity/institutional-portfolio/altium-capital-management-lp-1058946
Very interesting late buys last Friday ? Is the overhang gone if not should be the price is sticking a bit. I hope them MMs not up to there old tricks.
I still say news before Friday. They have to get them Aqustem shares matched with a price by next Monday.
Great news, what a opportunity for TILS and there treatment corvid 19 to be fast- tracked and make there name more prevalent among the crowd with a product that can mean a difference.
Lets hope they take the opportunity this could be big for them and of coarse there share holders.
Expecting news on the 20th of February, or before would make more sense.
The next news on here hopefully share moving north news, hopefully to new highs. Then will come the news for Accustem this should then cement its price and create a bit of stability.
Hoping at a price of about 89p/1.20p ready for the acquisition which given the demerger and the subsequent time delay is more than likely on the cards.
On the Nasdaq the amount of iis investors up to 24 now and 5.4 mill shares bagged so steam building there, and MORGAN STANLEY increasing its shares in this company month on month fills me with confidence as does the shorting percentage designed to lower the price till iis filled there pockets. The seller's here I would of said is dried up more or less and many sitting on averages here at to days price or higher.
TILS has a time line to catch the train before it leaves the station so the usual tools to part the Pis from there shares can only work for a time before the news has to break, not only that they should report this news as a matter of coarse and this does concern me.
price movement this week looks to me a bit of blind shorts rearing there ugly head before the inevitable rise next week, naughty little MMs.
Anyway best of luck to all
Seems we have a lot of negativity here, hope its well paid like it was in the nineties.
The reason its dropping is because of inpatient holders drip feeding, and the iis right behind picking up there cheap shares this has been going on months now, here and on the exchange for decades. Same in Nasdaq that's why there's 24 IIs invested there against 7 back in August and over doubled there interest. Its amazing some of the Pis have any money at all if they cant read this they haven't got a chance. Patients is the key hold them shares and see the return don't play there game.
MMs want it all ways my broker has set a reduced limit of 50% why this figure who knows but it come down from 100% so be careful.
The last paragraph of the RNS is quite revealing for those that notice.
No longer -- could be ,,maybe ,, could help, maybe affective, shown to help, etc.
Now its saying.
{The company is accelerating development of anti-Interleukin 6 receptor (IL6R) mAb, a fully human monoclonal antibody for treatment of IL6-induced inflammation, especially for treatment of COVID-19 patients.}
Main news due on this soon but looking very very positive. If they are speeding things up, we can get this to the market early and cheaply due to covid-19 need ? win win
The Last part of this RNS very interesting ? Why unless it works and will be rolled out. I Think more to come with the results and it's looking good.
"The company is accelerating development of anti-Interleukin 6 receptor (IL6R) mAb, a fully human monoclonal."
The comment below looks very exciting is it acknowledgement that we have some feedback from the trial.
The company is accelerating development of anti-Interleukin 6 receptor (IL6R) mAb, a fully human monoclonal antibody for treatment of IL6-induced inflammation, especially for treatment of COVID-19 patients.
Even with this latest to good to be true deal Pi 'S selling into any rise , and who can blame them.
Art has lost the trust that seems clear and with this type of deal it will take 6 mouths to see the wood from the trees .today's fall who seem that coming ? Well someone has to me it looks like the MM. S are using your Pi money to bet against them and guess who always wins there.
The news I was hoping for looks like it's not coming hence this deal to distract Pi's other wise he would of kept this for pudding after Nigeria put to bed so what do we have?
We have what looks like a good deal that good we haven't signed it with no 3rd party auditing or oversight on a private deal with no figures you can take to the bank, Nigeria oil fields with no paper work to do anything with and what's looking more and more built on sand. Oh and Mozambique.
Art you have played your last hand on AIM and there's only two reasons Art comes to London,
To raise money , to feed the Bulls with ****e , to discuss how much longer the MMS will allow him to keep his job. Best of luck here by the way but that's my last bet with this donkey.
Davey been asking that for 3 months while I watch this slide, can only assume they are washing out the weak and its working they are picking up shares as they are sold.
All points to a massive rise when news comes. you gotta have faith the MMs are ripping you off short term, be glad when I see the back of AIM and its ways, call this investment it should carry a government wealth warning?
Markat :good post and for me a good approximation of our point in time.
There was one valuation at £240 mil put on Accustem I recall but at this stage it all about what someone is going to pay for it and not that many in the market to buy it but for some lots at stake.
I think TILS investors have been dealt a from stacked deck of cards with most if not all hands already on the table? Why would a couple of investment companies by in to Tils and launched on Nasdaq as well, when London main market was there.
The losses on there investment is now £30 mill and one wonders why the shorts are running at 25% . From what was surgested Stem would be up and running by late December, now looking to be sometime H 1 2021. With all that said there's more questions than answers,so you can understand the frustration of the investors, and that telephone conference what was that all about I new they couldn't answer questions not in the public domain so
I asked one they could and they never even answered it in full, very poor show or was it ?
What ever is in the pipeline its big behind every sell is a buyer and we have gone from over sold to over bought but no rise ? Stem is sat there in limbo and as time goes on seems to represent more value that first relised given the fall in Tils. We will have to wait until they turn the rest of the cards to see the play in the meantime that pick up more cheap shares with not that many buyers to force them to increase the price.